| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 3 |
| 1 | GEMCITABINE | 2 |
| 2 | GEMCITABINE HYDROCHLORIDE | 2 |
| 3 | PEMBROLIZUMAB | 2 |
| 4 | ASPIRIN | 1 |
| 5 | ASPIRIN 325 MG | 1 |
| 6 | ASPIRIN 81 MG | 1 |
| 7 | CAPECITABINE | 1 |
| 8 | DEUCRAVACITINIB | 1 |
| 9 | DURVALUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEUCRAVACITINIB | 1 | 0.0003 |
| 1 | GOLIMUMAB | 1 | 0.0001 |
| 2 | DURVALUMAB | 1 | 0.0000 |
| 3 | CISPLATIN | 3 | 0.0000 |
| 4 | GEMCITABINE HYDROCHLORIDE | 2 | 0.0000 |
| 5 | PEMBROLIZUMAB | 2 | 0.0000 |
| 6 | TRASTUZUMAB | 1 | 0.0000 |
| 7 | CAPECITABINE | 1 | 0.0000 |
| 8 | TERIPARATIDE | 1 | 0.0000 |
| 9 | TOCILIZUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 1 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 3 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 5 | Parathyroid Hormone Analog [EPC] | 1 | 0.0000 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Insulin Analog [EPC] | 1 | 0.0000 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 1 | 0.0000 |